Company: MIRM
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001759425-25-000054
Chunk: 398

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 8
Chunk 398
---
 and diluted$2,905 $(14,235)$(17,633)$(64,152)Denominator:Weighted-average shares of common stock outstanding, basic50,639,23147,782,61949,758,10447,316,789Effect of dilutive securities:Options to purchase common stock and restricted stock units6,339,795———Employee stock purchase plan contingently issuable14,815———Weighted-average shares of common stock outstanding, diluted56,993,84147,782,61949,758,10447,316,789Net income (loss) per share, basic$0.06 $(0.30)$(0.35)$(1.36)Net income (loss) per share, diluted$0.05 $(0.30)$(0.35)$(1.36)

10

The following outstanding potential dilutive shares have been excluded from the calculation of diluted net income (loss) per share for the periods presented due to their anti-dilutive effect:Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Options to purchase common stock and restricted stock units1,881,06011,853,26111,183,25211,853,261Common stock issuable upon conversion of convertible notes9,963,7119,964,2479,963,7119,964,247Employee stock purchase plan contingently issuable—69,10950,12469,109Total11,844,77121,886,61721,197,08721,886,617Recent Accounting Pronouncements Not Yet AdoptedFrom time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the accompanying unaudited condensed consolidated financial statements and disclosures.In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). This new guidance is designed to enhance the transparency and decision usefulness of income tax disclosures. The amendments of this update are related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for fiscal years beginning after December 15,